Utilizing the scale-X™ hydro system, BIONET aims to enhance the production of extracellular vesicles produced by Mesenchymal Stem Cells (MSCs) for clinical use. This development is a notable advancement in the mass production of standardized cell and gene therapies.
Read article "BIONET and Univercells Technologies’ collaboration propels mass production of exosomes with scale-X™ bioreactor integration"March 2024
Gareth Crothers, Operations Director at Univercells Technologies discussed the supply challenges and the strategy put in place to meet growing demand.
Read article "Supply challenges and key considerations on cleanroom expansion"